CORE LITHIUM LTD — Director's Dealing 2017

Aug 1, 2017

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity	Core Exploration Limited
ABN	80 146 287 809

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	StephenBIGGINS
Date of last notice	19 August 2016

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest	Indirect
Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest.	1. Mr Biggins is a director of and has a beneficial interest in the registered holder Nowak Investments Pty Ltd ATF The Nowak Superannuation Fund (Nowak) 2. Mr Biggins is a director of and has a beneficial interest in the registered holder Genex Resources Pty Ltd ATF Biggins Resources FamilyTrust(Genex)
Date of change	27 July 2017 and 2 August 2017

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

No. of securities held prior to change	5,791,000 Shares held by Nowak 1,216,667 Shares held by Genex 1,000,000 Quoted Options held by Nowak 1,100,000 Quoted Options held by Genex 3,000,000 unlisted Performance Rights subject to vesting criteria, expiring at various times to 30 September 2019 held by Genex
Class	Shares - Fully paid ordinary shares. Quoted Options – quoted options exercisable at 5 cents by 31 August 2017. Performance Rights – subject to satisfaction of performance conditions.
Number acquired	1,000,000 Shares
Number disposed	1,500,000 Performance Rights
Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation	Nil
No. of securities held after change	5,791,000 Shares held by Nowak 2,216,667 Shares held by Genex 1,000,000 Quoted Options held by Nowak 1,100,000 Quoted Options held by Genex 1,500,000 unlisted Performance Rights subject to vesting criteria, expiring at various times to 30 September 2019 held by Genex
Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back	Meeting of Capital Management and Project & Business Development KPI’s, vesting of Performance Rights and exercise of 1,000,000 Performance Rights. Lapse of 500,000 Performance Rights – performance conditions not met related toJoint Venture KPI.

• See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011

Appendix 3Y Change of Director’s Interest Notice

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract	Not applicable
Nature of interest
Name of registered holder (if issued securities)
Date of change
No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed
Interest acquired
Interest disposed
Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation
Interest after change

Part 3 –[+] Closed period

Were the interests in the securities or contracts detailed Not applicable above traded during a[+] closed period where prior written clearance was required? If so, was prior written clearance provided to allow the trade to proceed during this period? If prior written clearance was provided, on what date was this provided?

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 3